{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:29:18Z","timestamp":1784291358100,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011103","name":"European Commission Sixth Framework Programme","doi-asserted-by":"publisher","award":["676421"],"award-info":[{"award-number":["676421"]}],"id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50006\/2020"],"award-info":[{"award-number":["UIDP\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015621","name":"Applied Molecular Biosciences Unit","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100015621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bmc.2021.116530","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T21:21:34Z","timestamp":1637961694000},"page":"116530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Rui P.S.","family":"Patr\u00edcio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Videira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florbela","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116530_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.4.1.1","article-title":"P53 \u2013 Oncogene or anti-oncogene","volume":"4","author":"Lane","year":"1990","journal-title":"Genes Dev"},{"key":"10.1016\/j.bmc.2021.116530_b0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bmc.2021.116530_b0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/med.21393","article-title":"Medicinal chemistry strategies to disrupt the p53-MDM2\/MDMX interaction","volume":"36","author":"Lemos","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2021.116530_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3748\/wjg.v21.i1.84","article-title":"p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bmc.2021.116530_b0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting mutant p53 for efficient cancer therapy","volume":"18","author":"Bykov","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2021.116530_b0030","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1073\/pnas.1203789109","article-title":"Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization","volume":"109","author":"Graves","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2021.116530_b0035","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ci400348f","article-title":"Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors","volume":"53","author":"Xue","year":"2013","journal-title":"J ChemInf Model"},{"key":"10.1016\/j.bmc.2021.116530_b0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1747-0285.2012.01428.x","article-title":"Identification of FDA-approved drugs that computationally bind to MDM2","volume":"80","author":"Warner","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2021.116530_b0045","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1021\/ci100113p","article-title":"Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction","volume":"50","author":"Dezi","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2021.116530_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/minf.201300137","article-title":"Prediction of protein-protein interaction pocket using L-shaped PLS approach and its visualizations by generative topographic mapping","volume":"33","author":"Hasegawa","year":"2014","journal-title":"Mol Inform"},{"key":"10.1016\/j.bmc.2021.116530_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7750\/BioDiscovery.2013.8.4","article-title":"Small molecule inhibitors of MDM2-p53 and MDMX-p53 interactions as new cancer therapeutics","author":"Zhao","year":"2013","journal-title":"BioDiscovery"},{"key":"10.1016\/j.bmc.2021.116530_b0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41419-019-2074-3","article-title":"RITA requires eIF2 alpha-dependent modulation of mRNA translation for its anti-cancer activity","volume":"10","author":"Ristau","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2021.116530_b0065","series-title":"Global cancer observatory: cancer today","author":"Ferlay","year":"2018"},{"key":"10.1016\/j.bmc.2021.116530_b0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"10.1016\/j.bmc.2021.116530_b0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1517\/17460441.2015.1016497","article-title":"Maximizing computational tools for successful drug discovery","volume":"10","author":"Nantasenamat","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2021.116530_b0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/molecules21020151","article-title":"Chemoinformatics: achievements and challenges, a personal view","volume":"21","author":"Gasteiger","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2021.116530_b0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cmdc.201100510","article-title":"Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu5): from an artificial neural network virtual screen to an in vivo tool compound","volume":"7","author":"Mueller","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2021.116530_b0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2021.116530_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.csbj.2016.04.004","article-title":"Computational approaches in target identification and drug discovery","volume":"14","author":"Katsila","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.bmc.2021.116530_b0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/0022-3859.58943","article-title":"Structure-based drug design and modern medicine","volume":"55","author":"Vijayakrishnan","year":"2009","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.bmc.2021.116530_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/156802610790232251","article-title":"Successful applications of computer aided drug discovery: moving drugs from concept to the clinic","volume":"10","author":"Talele","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-007-9142-y","article-title":"Computer-aided drug design: the next 20 years","volume":"21","author":"Van Drie","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2021.116530_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/17460441.1.2.103","article-title":"What has computer-aided molecular design ever done for drug discovery?","volume":"1","author":"Clark","year":"2006","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2021.116530_b0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ejmech.2014.12.011","article-title":"Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents","volume":"90","author":"Mondal","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jmgm.2014.04.015","article-title":"Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2","volume":"51","author":"Goyal","year":"2014","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2021.116530_b0130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11224-015-0697-2","article-title":"Computational identification of novel piperidine derivatives as potential HDM2 inhibitors designed by fragment-based QSAR, molecular docking and molecular dynamics simulations","volume":"27","author":"Singh","year":"2016","journal-title":"Struct Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0135","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3390\/ijms21082924","article-title":"Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of novel 2- (4-amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio -4-chloro-5-me thyl-N-(1H-benzo d imidazol-2(3H)-ylidene)Benzenesulfonamides","volume":"21","author":"Tomorowicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116530_b0140","doi-asserted-by":"crossref","first-page":"22939","DOI":"10.1039\/D0RA04028B","article-title":"A novel artificial intelligence protocol to investigate potential leads for Parkinson's disease","volume":"10","author":"Chen","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2021.116530_b0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom8030056","article-title":"In Silico HCT116 human colon cancer cell-based models en route to the discovery of lead-like anticancer drugs","volume":"8","author":"Cruz","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2021.116530_b0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ejmech.2018.07.037","article-title":"Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: synthesis of a small library and evaluation of potential antitumor activity","volume":"156","author":"Brandao","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jmgm.2017.02.014","article-title":"Performance of a docking\/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of MDMX","volume":"74","author":"Bharatham","year":"2017","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2021.116530_b0160","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bmc.2021.116530_b0165","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15-ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J ChemInf Model"},{"key":"10.1016\/j.bmc.2021.116530_b0170","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0175","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0180","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/qsar.200420071","article-title":"Identification and classification of GPCR ligands using self-organizing neural networks","volume":"24","author":"Selzer","year":"2005","journal-title":"QSAR Comb Sci"},{"key":"10.1016\/j.bmc.2021.116530_b0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chemolab.2014.03.011","article-title":"A QSPR approach for the fast estimation of DFT\/NBO partial atomic charges","volume":"134","author":"Zhang","year":"2014","journal-title":"Chemom Intell Lab Syst"},{"key":"10.1016\/j.bmc.2021.116530_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.bmc.2021.116530_b0195","unstructured":"Hall MA, Smith LA. Correlation-based feature selection for machine learning. In: AAAI Press: Menlo Park CA, USA (ed). Twelfth international FLAIRS conference. Orlando, FL, USA, 1999. p. 235."},{"key":"10.1016\/j.bmc.2021.116530_b0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1145\/1656274.1656278","article-title":"The WEKA data mining software: an update","volume":"11","author":"Hall","year":"2009","journal-title":"SIGKDD Explor Newsl"},{"key":"10.1016\/j.bmc.2021.116530_b0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10822-018-0116-z","article-title":"Ecker, Comparing the performance of meta-classifiers-a case study on selected imbalanced data sets relevant for prediction of liver toxicity","volume":"32","author":"Jain","year":"2018","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.bmc.2021.116530_b0210","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2020. https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.bmc.2021.116530_b0215","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random forest: a classification and regression tool for compound classification and QSAR modeling","volume":"43","author":"Svetnik","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.bmc.2021.116530_b0220","first-page":"18","article-title":"Classification and regression by randomforest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News"},{"key":"10.1016\/j.bmc.2021.116530_b0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022627411411","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach Learn"},{"key":"10.1016\/j.bmc.2021.116530_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/1961189.1961199","article-title":"LIBSVM: a library for support vector machines","volume":"2","author":"Chang","year":"2011","journal-title":"ACM Trans Intell Syst Technol"},{"key":"10.1016\/j.bmc.2021.116530_b0235","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"10.1016\/j.bmc.2021.116530_b0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0245","doi-asserted-by":"crossref","DOI":"10.1002\/app.47191","article-title":"Polymer blending or fiber blending: a comparative study using chitosan and poly(epsilon-caprolactone) electrospun fibers","volume":"136","author":"Valente","year":"2019","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.bmc.2021.116530_b0250","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2021.116530_b0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/md12020757","article-title":"A chemoinformatics approach to the discovery of lead-like molecules from marine and microbial sources En route to antitumor and antibiotic drugs","volume":"12","author":"Pereira","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.bmc.2021.116530_b0265","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1021\/ci600563w","article-title":"Ensemble feature selection: consistent descriptor subsets for multiple QSAR models","volume":"47","author":"Dutta","year":"2007","journal-title":"J ChemInf Model"},{"key":"10.1016\/j.bmc.2021.116530_b0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-7439(01)00171-X","article-title":"JATOON: Java tools for neural networks","volume":"61","author":"Aires-de-Sousa","year":"2002","journal-title":"Chemom Intell Lab Syst"},{"key":"10.1016\/j.bmc.2021.116530_b0275","first-page":"4526","article-title":"Sequential treatment with celecoxib and bortezomib enhances the ER stress-mediated autophagy-associated cell death of colon cancer cells","volume":"16","author":"Park","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2021.116530_b0280","first-page":"382","article-title":"Gambogic acid counteracts mutant p53 stability by inducing autophagy","volume":"1864","author":"Foggetti","year":"2017","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2021.116530_b0285","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1208\/s12249-015-0339-4","article-title":"Recent research on bioactive Xanthones from natural medicine: Garcinia hanburyi","volume":"16","author":"Jia","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bmc.2021.116530_b0290","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/molecules23061394","article-title":"Anti-tumorigenic activity of Chrysin from oroxylum indicum via non-genotoxic p53 activation through the ATM-Chk2 pathway","volume":"23","author":"Nagasaka","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2021.116530_b0295","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1074\/jbc.M809096200","article-title":"Crystal structures of human MDMX (HDMX) in complex with p53 peptide analogues reveal surprising conformational changes","volume":"284","author":"Kallen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0300","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116530_b0305","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/jm400311n","article-title":"Synthesis, in vitro, and in cell studies of a new series of indoline-3,2 '-thiazolidine -based p53 modulators","volume":"56","author":"Bertamino","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0310","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1021\/jm300969t","article-title":"Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction","volume":"55","author":"Zhuang","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0315","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.bmc.2013.03.061","article-title":"Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1","volume":"21","author":"Wang","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0320","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.bmcl.2014.02.055","article-title":"Core modification of substituted piperidines as Novel inhibitors of HDM2-p53 protein-protein interaction","volume":"24","author":"Pan","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116530_b0325","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejmech.2012.08.003","article-title":"Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors","volume":"56","author":"Guo","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116530_b0330","first-page":"1381","article-title":"Dihydroergocristine - review of pharmacology and toxicology","volume":"42","author":"Coppi","year":"1992","journal-title":"Arzneimittelforschung"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:29:43Z","timestamp":1778574583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621005381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":66,"alternative-id":["S0968089621005381"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116530","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116530"}}